Profilo
Claes Ekstrom is currently the Managing Director & Head of Life Sciences Lending at Innovatus Capital Partners LLC since 2016.
He is also currently serving as the Chief Business Officer at Innovatus Life Sciences Acquisition Corp.
since 2021.
Previously, Claes worked as the Managing Director at Bentley Associates LP from 2009 to 2011.
He holds a graduate degree from Stockholm School of Economics.
Posizioni attive di Claes Ekstrom
| Società | Posizione | Inizio |
|---|---|---|
Innovatus Capital Partners LLC
Innovatus Capital Partners LLC Investment ManagersFinance Innovatus Capital invests in public and private companies located in the United States. The firm focuses on real estate and life science sectors. It provides financing in the form of debt and equity for growth and buyout stage capital requirements with an investment size of USD 20 - 150 million for life sciences. | Investitore di Private Equity | 01/01/2016 |
Innovatus Life Sciences Acquisition Corp.
Innovatus Life Sciences Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Corporate Officer/Principal | 08/01/2021 |
Precedenti posizioni note di Claes Ekstrom
| Società | Posizione | Fine |
|---|---|---|
Bentley Associates LP
Bentley Associates LP Investment Banks/BrokersFinance Provides financial advisory services | Investitore di Private Equity | 31/12/2011 |
Formazione di Claes Ekstrom
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Bentley Associates LP
Bentley Associates LP Investment Banks/BrokersFinance Provides financial advisory services | Finance |
Stockholm School of Economics
Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innovatus Capital Partners LLC
Innovatus Capital Partners LLC Investment ManagersFinance Innovatus Capital invests in public and private companies located in the United States. The firm focuses on real estate and life science sectors. It provides financing in the form of debt and equity for growth and buyout stage capital requirements with an investment size of USD 20 - 150 million for life sciences. | Finance |
Innovatus Life Sciences Acquisition Corp.
Innovatus Life Sciences Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
















